Form 8-K EXACT SCIENCES CORP For: Feb 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Exact Sciences (EXAS) Tops Q4 EPS by 6c, FY Rev. Guidance Beats
February 21, 2019 4:22 PM ESTExact Sciences (NASDAQ: EXAS) reported Q4 EPS of ($0.44), $0.06 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $143 million versus the consensus estimate of $134.84 million.
GUIDANCE:
Exact Sciences sees FY2019 revenue of $710-730 million, versus the consensus of... More



